GlassScriptPhysician profile
Eugene Goykhman
NPI 1346381720
$5,072.33
in general payments reported to CMS, 2019-2025
28 companies · $1,173 in 2025
The $1,173 reported for 2025 was more than what 80% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $777 · 2020: $406 · 2021: $366 · 2022: $794 · 2023: $742 · 2024: $815 · 2025: $1,173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,730.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,729.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,721.40 | 2019-2025 | Nucala, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $774.59 | 2019-2025 | Tezspire, Airsupra, Breztri |
| Abbvie INC. | $363.95 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $300.53 | 2019-2025 | |
| Genentech USA, INC. | $170.72 | 2019-2023 | Xolair |
| Janssen Pharmaceuticals, INC | $163.66 | 2019-2020 | |
| Insmed, INC. | $159.22 | 2021-2025 | Arikayce |
| Merck Sharp & Dohme LLC | $149.66 | 2019-2024 | Keytruda |
| Baxter Healthcare | $139.56 | 2022-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System, Hillrom - Life 2000 Ventilation System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $129.10 | 2019-2022 | |
| Electromed, INC. | $114.13 | 2019-2025 | Smartvest |
| Amgen INC. | $111.70 | 2024-2025 | Tezspire |
| Jazz Pharmaceuticals INC. | $106.77 | 2019-2024 | |
| Grifols USA, LLC | $100.19 | 2021-2025 | Prolastin-C Liquid |
| Genzyme Corporation | $97.64 | 2022-2024 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $82.58 | 2023-2024 | Wakix |
| Regeneron Healthcare Solutions, INC. | $79.45 | 2020-2025 | Dupixent |
| Mylan Specialty L.P. | $55.89 | 2019-2021 | |
| Pfizer INC. | $37.82 | 2019-2025 | |
| Shire North American Group INC | $36.99 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $34.92 | 2019-2020 | |
| Verona Pharma, INC. | $29.24 | 2025 | Ohtuvayre |
| Gilead Sciences, INC. | $23.42 | 2019 | |
| Philips North America LLC | $22.44 | 2019 | |
| Sunovion Pharmaceuticals INC. | $19.00 | 2019 | |
| United Therapeutics Corporation | $18.72 | 2019 | |
| Phathom Pharmaceuticals, INC. | $18.00 | 2025 | Voquezna |
| Circassia INC. | $11.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Goykhman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.